ALZN   $1.62  -2.41% Market Closed After Close 1.59 -1.85%

Alzamend Neuro Inc
Total Cash 1.19M
totalCashPerShare 0.307
EBITDA -7.32M
Total Debt 0.00
quickRatio 0.414
currentRatio 0.491
Total Revenue
debtToEquity
Revenue/Share
ROA -2.1447098
ROE
grossProfits
freeCashflow -3.36M
operatingCashflow -6.03M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 5.30M
forwardPE -0.14690265
floatShares 3.78M
sharesOutstanding 4.48M
sharesShort 103.17K
sharesShortPriorMonth 67.93K
dateShortInterest
sharesPercentSharesOut 0.03%
heldPercentInsiders 0.05%
heldPercentInstitutions 0.01%
Short Ratio help_outline 0.27%
shortPercentOfFloat 0.03%
impliedSharesOutstanding
bookValue -1.407
Price To Book help_outline
earningsQuarterlyGrowth
netIncomeToCommon -7.39M
trailingEps -142.87%
forwardEps -11.30%
enterpriseToEbitda -0.72
lastDividendValue
lastDividendDate
currentQuarterEstimate -2.38 4Q 2024
institutionsCount 17
lastUpdated Oct. 17, 2024, 12:03 a.m.